pyrazines has been researched along with y-39983 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HH; Combrink, KD; Drace, C; Hellberg, MR; Kelly, C; Li, B; McLaughlin, MA; Namil, A; Pang, IH; Patil, R; Rusinko, A; Severns, B; Sharif, N; Ward, J; Yacoub, S | 1 |
1 other study(ies) available for pyrazines and y-39983
Article | Year |
---|---|
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Glaucoma; Guinea Pigs; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrazines; Pyridines; rho-Associated Kinases | 2014 |